MedTrace Logo

Navi-Star Thermo-Cool Catheter For Ablation of Atrial Fibrillation

NCT00584415 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 119

Last updated 2014-07-28

Study results available
· View outcomes & findings →

Summary

The objective of this study is to demonstrate that the NAVI-STAR THERMO-COOL catheter can be used to safely and effectively reduce symptomatic episodes of paroxysmal atrial fibrillation in patients with frequent (\>3 episodes/month) or infrequent \<3 episodes/month)atrial fibrillation resistant to at least one Class I or Class III antiarrhythmic drug.

Conditions

  • Paroxysmal Atrial Fibrillation

Interventions

DEVICE

GP ablation + PV isolation

All patients underwent GP ablation and PV isolation using the NaviStar ThermoCool ablation catheter

Sponsors & Collaborators

  • University of Oklahoma

    lead OTHER

Principal Investigators

  • Sunny Po, MD · University of Oklahoma

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-02-29
Primary Completion
2009-02-28
Completion
2009-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00584415 on ClinicalTrials.gov